Global Neuromyelitis Optica Drug Industry 2016 Deep Market Research Report

Table of Contents

1 Industry Overview 1
1.1 Definition and Specifications of Neuromyelitis Optica Drug 1
1.1.1 Definition of Neuromyelitis Optica Drug 1
1.1.2 Specifications of Neuromyelitis Optica Drug 2
1.2 Classification of Neuromyelitis Optica Drug 2
1.2.1 Glucocorticoids 3
1.2.2 Immunoglobulin 4
1.3 Applications of Neuromyelitis Optica Drug 5
1.3.1 Acute attack 5
1.3.2 Remission prophylactic treatment 6
1.4 Industry Chain Structure of Neuromyelitis Optica Drug 8
1.5 Industry Overview and Major Regions Status of Neuromyelitis Optica Drug 8
1.5.1 Industry Overview of Neuromyelitis Optica Drug 8
1.5.2 Global Major Regions Status of Neuromyelitis Optica Drug 9
1.6 Industry Policy Analysis of Neuromyelitis Optica Drug 9
1.7 Industry News Analysis of Neuromyelitis Optica Drug 10
2 Manufacturing Cost Structure Analysis of Neuromyelitis Optica Drug 12
2.1 Raw Material Suppliers Analysis of Neuromyelitis Optica Drug 12
2.2 Equipment Suppliers Analysis of Neuromyelitis Optica Drug 12
2.3 Labor Cost Analysis of Neuromyelitis Optica Drug 13
2.4 Other Costs Analysis of Neuromyelitis Optica Drug 16
2.5 Manufacturing Cost Structure Analysis of Neuromyelitis Optica Drug 16
2.6 Manufacturing Process Analysis of Neuromyelitis Optica Drug 17
3 Technical Data and Manufacturing Plants Analysis 18
3.1 Capacity and Commercial Production Date of Global Key Manufacturers in 2015 18
3.2 Manufacturing Plants Distribution of Global Key Neuromyelitis Optica Drug Manufacturers in 2015 18
3.3 R&D Status and Technology Source of Global Neuromyelitis Optica Drug Key Manufacturers in 2015 19
4 Capacity, Production and Revenue Analysis of Neuromyelitis Optica Drug by Regions, Types and Manufacturers 20
4.1 Global Capacity, Production and Revenue of Neuromyelitis Optica Drug by Regions 2011-2016 20
4.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Neuromyelitis Optica Drug 2011-2016 24
4.3 Global Capacity, Production and Revenue of Neuromyelitis Optica Drug by Types 2011-2016 31
4.4 Global Capacity, Production and Revenue of Neuromyelitis Optica Drug by Manufacturers 2011-2016 35
5 Price, Cost, Gross and Gross Margin Analysis of Neuromyelitis Optica Drug by Regions, Types and Manufacturers 42
5.1 Price, Cost, Gross and Gross Margin Analysis of Neuromyelitis Optica Drug by Regions 2011-2016 42
5.2 Price, Cost, Gross and Gross Margin Analysis of Neuromyelitis Optica Drug by Types 2011-2016 45
5.3 Price, Cost, Gross and Gross Margin Analysis of Neuromyelitis Optica Drug by Manufacturers 2011-2016 47
6 Consumption Volume, Consumption Value and Sale Price Analysis of Neuromyelitis Optica Drug by Regions, Types and Applications 52
6.1 Global Consumption Volume and Consumption Value of Neuromyelitis Optica Drug by Regions 2011-2016 52
6.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Neuromyelitis Optica Drug 2011-2016 55
6.3 Global Consumption Volume and Consumption Value of Neuromyelitis Optica Drug by Types 2011-2016 60
6.4 Global Consumption Volume and Consumption Value of Neuromyelitis Optica Drug by Applications 2011-2016 63
6.5 Sale Price of Neuromyelitis Optica Drug by Regions 2011-2016 66
6.6 Sale Price of Neuromyelitis Optica Drug by Types 2011-2016 66
6.7 Sale Price of Neuromyelitis Optica Drug by Applications 2011-2016 66
7 Supply, Import, Export and Consumption Analysis of Neuromyelitis Optica Drug 67
7.1 Supply, Consumption and Gap of Neuromyelitis Optica Drug 2011-2016 67
7.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 68
7.3 North America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 69
7.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 70
7.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 70
7.6 Asia (Ex China) Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 71
8 Analysis of Neuromyelitis Optica Drug Industry Key Manufacturers 73
8.1 Pfizer 73
8.1.1 Company Profile 73
8.1.2 Product Information 74
8.1.3 Capacity, Production, Price, Cost, Gross, and Revenue 74
8.2 Fresenius 76
8.2.1 Company Profile 76
8.2.2 Product Information 77
8.2.3 Capacity, Production, Price, Cost, Gross, and Revenue 78
8.3 TEVA 80
8.3.1 Company Profile 80
8.3.2 Product Information 81
8.3.3 Capacity, Production, Price, Cost, Gross, and Revenue 81
8.4 Sandoz 83
8.4.1 Company Profile 83
8.4.2 Product Information 84
8.4.3 Capacity, Production, Price, Cost, Gross, and Revenue 84
8.5 Intas 86
8.5.1 Company Profile 86
8.5.2 Product Information 87
8.5.3 Capacity, Production, Price, Cost, Gross, and Revenue 87
8.6 Gyjtrs 89
8.6.1 Company Profile 89
8.6.2 Product Information 90
8.6.3 Capacity, Production, Price, Cost, Gross, and Revenue 90
8.7 Nang Kuang 92
8.7.1 Company Profile 92
8.7.2 Product Information 93
8.7.3 Capacity, Production, Price, Cost, Gross, and Revenue 93
8.8 Tianjin Kingyork 95
8.8.1 Company Profile 95
8.8.2 Product Information 96
8.8.3 Capacity, Production, Price, Cost, Gross, and Revenue 96
8.9 Baxter 98
8.9.1 Company Profile 98
8.9.2 Product Picture and Specifications 99
8.9.3 Capacity, Production, Price, Cost, Gross, and Revenue 99
8.10 CSL 101
8.10.1 Company Profile 101
8.10.2 Product Picture and Specifications 102
8.10.3 Capacity, Production, Price, Cost, Gross, and Revenue 102
8.11 Grifols 104
8.11.1 Company Profile 104
8.11.2 Product Picture and Specifications 105
8.11.3 Capacity, Production, Price, Cost, Gross, and Revenue 107
8.12 Octapharma 108
8.12.1 Company Profile 108
8.12.2 Product Picture and Specifications 109
8.12.3 Capacity, Production, Price, Cost, Gross, and Revenue 109
8.13 CBOP 111
8.13.1 Company Profile 111
8.13.2 Product Picture 112
8.13.3 Capacity, Production, Price, Cost, Gross, and Revenue 112
9 Marketing Trader or Distributor Analysis of Neuromyelitis Optica Drug 114
9.1 Marketing Channels Status of Neuromyelitis Optica Drug 114
9.2 Traders or Distributors with Contact Information of Neuromyelitis Optica Drug by Regions 114
9.3 Ex-work Price, Channel Price and End Buyer Price Analysis of Neuromyelitis Optica Drug 116
9.4 Regional Import, Export and Trade Analysis of Neuromyelitis Optica Drug 116
10 Industry Chain Analysis of Neuromyelitis Optica Drug 118
10.1 Major Raw Materials Suppliers with Contact Information Analysis of Neuromyelitis Optica Drug 118
10.2 Major Equipment Suppliers with Contact Information Analysis of Neuromyelitis Optica Drug 119
10.3 Major Consumers with Contact Information Analysis of Neuromyelitis Optica Drug 119
10.4 Supply Chain Relationship Analysis of Neuromyelitis Optica Drug 121
11 Development Trend of Analysis of Neuromyelitis Optica Drug 122
11.1 Capacity, Production and Revenue Forecast of Neuromyelitis Optica Drug by Regions and Types 122
11.1.1 Global Capacity, Production and Revenue of Neuromyelitis Optica Drug by Regions 2016-2021 122
11.1.2 Global and Major Regions Capacity, Production, Revenue and Growth Rate of Neuromyelitis Optica Drug 2016-2021 126
11.1.3 Global Capacity, Production and Revenue of Neuromyelitis Optica Drug by Types 2016-2021 133
11.2 Consumption Volume and Consumption Value Forecast of Neuromyelitis Optica Drug by Regions, Types and Applications 137
11.2.1 Global Consumption Volume and Consumption Value of Neuromyelitis Optica Drug by Regions 2016-2021 137
11.2.2 Global and Major Regions Consumption Volume, Consumption Value and Growth Rate of Neuromyelitis Optica Drug 2016-2021 140
11.2.3 Global Consumption Volume and Consumption Value of Neuromyelitis Optica Drug by Types 2016-2021 145
11.2.4 Global Consumption Volume and Consumption Value of Neuromyelitis Optica Drug by Applications 2016-2021 148
11.3 Supply, Import, Export and Consumption Forecast of Neuromyelitis Optica Drug 151
11.3.1 Supply, Consumption and Gap of Neuromyelitis Optica Drug 2016-2021 151
11.3.2 Global Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 152
11.3.3 North America Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 153
11.3.4 Europe Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 153
11.3.5 China Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 154
11.3.6 Asia (Ex China) Capacity, Production, Price, Cost, Revenue, Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 155
12 New Project Investment Feasibility Analysis of Neuromyelitis Optica Drug 156
12.1 New Project SWOT Analysis of Neuromyelitis Optica Drug 156
12.2 New Project Investment Feasibility Analysis of Neuromyelitis Optica Drug 156
12.2.1 Project Name 156
12.2.2 Investment Budget 157
12.2.3 Project Product Solutions 157
12.2.4 Project Schedule 157
13 Conclusion of the Global Neuromyelitis Optica Drug Industry 2016 Market Research Report 159
List of Tables and Figures

Figure Picture of Neuromyelitis Optica Drug 1
Table Comparison of Main Models from Neuromyelitis Optica Drug Major Manufacturers 2
Table Specification Comparison of Different Types of Neuromyelitis Optica Drug 2
Figure Global Production Market Share of Neuromyelitis Optica Drug by Type in 2015 3
Figure Glucocorticoids Picture 3
Table Major Manufacturers of Glucocorticoids 4
Figure Immunoglobulin Picture 4
Table Major Manufacturers of Immunoglobulin 4
Table Applications of Neuromyelitis Optica Drug 5
Figure 2015 Global Neuromyelitis Optica Drug Major Applications Sales Share 5
Figure Acute attack Examples 6
Table Major Consumers of Acute attack 6
Figure Remission prophylactic treatment Examples 7
Table Major Consumers of Remission prophylactic treatment 7
Figure Industry Chain Structure of Neuromyelitis Optica Drug 8
Table Global Neuromyelitis Optica Drug Major Manufacturers 8
Table Global Major Regions Neuromyelitis Optica Drug Development Status in 2015 9
Table Industry Policy of Neuromyelitis Optica Drug 9
Table Industry News List of Neuromyelitis Optica Drug 10
Table Raw Material Suppliers Analysis 11
Table Equipment Suppliers Analysis 11
Figure 2014 APAC Overview of Average Monthly Labor Cost 12
Figure 2014 Americas Overview of Average Monthly Labor Cost 13
Figure 2014 EMEA Overview of Average Monthly Labor Cost 13
Figure 2010-2015 USA Employment Cost Index (ECI) 14
Figure 2010-2014 China Average Wage of Worker and Growth Rate (CNY/a) 14
Table Manufacturing Cost Structure Analysis of Neuromyelitis Optica Drug in 2015 15
Figure Manufacturing Process Analysis of Neuromyelitis Optica Drug 16
Table Capacity (K Units) and Commercial Production Date of Global Neuromyelitis Optica Drug Key Manufacturers in 2015 17
Table Manufacturing Plants Distribution of Global Neuromyelitis Optica Drug Major Manufacturers in 2015 17
Table R&D Status and Technology Source of Global Neuromyelitis Optica Drug Key Manufacturers in 2015 18
Table Global Capacity (K Units) of Neuromyelitis Optica Drug by Regions 2011-2016 19
Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Regions in 2011 19
Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Regions in 2015 20
Table Global Production (K Units) of Neuromyelitis Optica Drug by Regions 2011-2016 20
Figure Global Production Market Share of Neuromyelitis Optica Drug by Regions in 2011 20
Figure Global Production Market Share of Neuromyelitis Optica Drug by Regions in 2015 21
Table Global Revenue (K USD) of Neuromyelitis Optica Drug by Regions 2011-2016 21
Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Regions in 2011 22
Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Regions in 2015 22
Figure Global Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 23
Figure Global Capacity Utilization Rate of Neuromyelitis Optica Drug 2011-2016 23
Figure Global Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 24
Figure North America Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 24
Figure North America Capacity Utilization Rate of Neuromyelitis Optica Drug 2011-2016 25
Figure North America Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 25
Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 26
Figure Europe Capacity Utilization Rate of Neuromyelitis Optica Drug 2011-2016 26
Figure Europe Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 27
Figure China Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 27
Figure China Capacity Utilization Rate of Neuromyelitis Optica Drug 2011-2016 28
Figure China Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 28
Figure Asia (Ex China) Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 29
Figure Asia (Ex China) Capacity Utilization Rate of Neuromyelitis Optica Drug 2011-2016 29
Figure Asia (Ex China) Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 30
Table Global Capacity (K Units) of Neuromyelitis Optica Drug by Types 2011-2016 30
Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Types in 2011 31
Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Types in 2015 31
Table Global Production (K Units) of Neuromyelitis Optica Drug by Types 2011-2016 31
Figure Global Production Market Share of Neuromyelitis Optica Drug by Types in 2011 32
Figure Global Production Market Share of Neuromyelitis Optica Drug by Types in 2015 32
Table Global Revenue (K USD) of Neuromyelitis Optica Drug by Types 2011-2016 33
Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Types in 2011 33
Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Types in 2015 34
Table Global and Major Manufacturers Capacity (K Units) of Neuromyelitis Optica Drug 2011-2016 34
Table Global Capacity Market Share of Neuromyelitis Optica Drug Major Manufacturers 2011-2016 35
Figure Global Capacity Market Share of Neuromyelitis Optica Drug Major Manufacturers in 2011 35
Figure Global Capacity Market Share of Neuromyelitis Optica Drug Major Manufacturers in 2015 36
Table Global and Major Manufacturers Production (K Units) of Neuromyelitis Optica Drug 2011-2016 36
Table Global Production Market Share of Neuromyelitis Optica Drug Major Manufacturers 2011-2016 37
Figure Global Production Market Share of Neuromyelitis Optica Drug Major Manufacturers in 2011 37
Figure Global Production Market Share of Neuromyelitis Optica Drug Major Manufacturers in 2015 38
Table Global and Major Manufacturers Revenue (K USD) of Neuromyelitis Optica Drug 2011-2016 38
Table Global Revenue Market Share of Neuromyelitis Optica Drug Major Manufacturers 2011-2016 39
Figure Global Revenue Market Share of Neuromyelitis Optica Drug Major Manufacturers in 2011 39
Figure Global Revenue Market Share of Neuromyelitis Optica Drug Major Manufacturers in 2015 40
Table Price (USD/Unit) of Neuromyelitis Optica Drug by Regions 2011-2016 41
Figure Price (USD/Unit) of Neuromyelitis Optica Drug by Regions in 2015 41
Table Cost (USD/Unit) of Neuromyelitis Optica Drug by Regions 2011-2016 41
Figure Cost (USD/Unit) of Neuromyelitis Optica Drug by Regions in 2015 42
Table Gross (USD/Unit) of Neuromyelitis Optica Drug by Regions 2011-2016 42
Figure Gross (USD/Unit) of Neuromyelitis Optica Drug by Regions in 2015 43
Table Gross Margin of Neuromyelitis Optica Drug by Regions 2011-2016 43
Figure Gross Margin of Neuromyelitis Optica Drug by Regions in 2015 43
Table Price (USD/Unit) of Neuromyelitis Optica Drug by Types 2011-2016 44
Figure Price (USD/Unit) of Neuromyelitis Optica Drug by Types in 2015 44
Table Cost (USD/Unit) of Neuromyelitis Optica Drug by Types 2011-2016 44
Figure Cost (USD/Unit) of Neuromyelitis Optica Drug by Types in 2015 45
Table Gross (USD/Unit) of Neuromyelitis Optica Drug by Types 2011-2016 45
Figure Gross (USD/Unit) of Neuromyelitis Optica Drug by Types in 2015 45
Table Gross Margin of Neuromyelitis Optica Drug by Types 2011-2016 45
Figure Gross Margin of Neuromyelitis Optica Drug by Types in 2015 46
Table Price (USD/Unit) of Neuromyelitis Optica Drug by Manufacturers 2011-2016 46
Figure Price (USD/Unit) of Neuromyelitis Optica Drug by Manufacturers in 2015 47
Table Cost (USD/Unit) of Neuromyelitis Optica Drug by Manufacturers 2011-2016 47
Figure Cost (USD/Unit) of Neuromyelitis Optica Drug by Manufacturers in 2015 48
Table Gross (USD/Unit) of Neuromyelitis Optica Drug by Manufacturers 2011-2016 48
Figure Gross (USD/Unit) of Neuromyelitis Optica Drug by Manufacturers in 2015 49
Table Gross Margin of Neuromyelitis Optica Drug by Manufacturers 2011-2016 49
Figure Gross Margin of Neuromyelitis Optica Drug by Manufacturers in 2015 50
Table Global Consumption Volume (K Units) of Neuromyelitis Optica Drug by Regions 2011-2016 51
Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Regions in 2011 52
Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Regions in 2015 52
Table Global Consumption Value (K USD) of Neuromyelitis Optica Drug by Regions 2011-2016 52
Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Regions in 2011 53
Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Regions in 2015 53
Figure Global Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 54
Figure Global Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 54
Figure North America Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 55
Figure North America Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 55
Figure Europe Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 56
Figure Europe Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 56
Figure China Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 57
Figure China Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 57
Figure Asia (Ex China) Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 58
Figure Asia (Ex China) Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2011-2016 58
Table Global Consumption Volume (K Units) of Neuromyelitis Optica Drug by Types 2011-2016 59
Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Types in 2011 59
Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Types in 2015 60
Table Global Consumption Value (K USD) of Neuromyelitis Optica Drug by Types 2011-2016 60
Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Types in 2011 61
Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Types in 2015 61
Table Global Consumption Volume (K Units) of Neuromyelitis Optica Drug by Applications 2011-2016 62
Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Applications in 2011 62
Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Applications in 2015 63
Table Global Consumption Value (K USD) of Neuromyelitis Optica Drug by Applications 2011-2016 63
Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Applications in 2011 64
Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Applications in 2015 64
Table Sale Price (USD/Unit) of Neuromyelitis Optica Drug by Regions 2011-2016 65
Table Sale Price (USD/Unit) of Neuromyelitis Optica Drug by Types 2011-2016 65
Table Sale Price (USD/Unit) of Neuromyelitis Optica Drug by Applications 2011-2016 65
Table Global Supply, Consumption and Gap of Neuromyelitis Optica Drug 2011-2016 (K Units) 66
Table North America Supply, Consumption and Gap of Neuromyelitis Optica Drug 2011-2016 (K Units) 66
Table Europe Supply, Consumption and Gap of Neuromyelitis Optica Drug 2011-2016 (K Units) 66
Table China Supply, Consumption and Gap of Neuromyelitis Optica Drug 2011-2016 (K Units) 66
Table Asia (Ex China) Supply, Consumption and Gap of Neuromyelitis Optica Drug 2011-2016 (K Units) 67
Table Global Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2011-2016 67
Table North America Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2011-2016 68
Table North America Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 (K Units) 68
Table Europe Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2011-2016 69
Table Europe Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 (K Units) 69
Table China Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2011-2016 69
Table China Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 (K Units) 70
Table Asia (Ex China) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2011-2016 70
Table Asia (Ex China) Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2011-2016 (K Units) 71
Table Pfizer Company Profile 72
Figure Neuromyelitis Optica Drug Product Picture 73
Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of Pfizer 2011-2016 73
Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Pfizer 2011-2016 74
Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Pfizer 2011-2016 74
Table Fresenius Company Profile 75
Figure Neuromyelitis Optica Drug Product Picture of Fresenius 76
Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of Fresenius 2011-2016 77
Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Fresenius 2011-2016 78
Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Fresenius 2011-2016 78
Table TEVA Company Profile 79
Figure Neuromyelitis Optica Drug Product Picture 80
Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of TEVA 2011-2016 80
Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of TEVA 2011-2016 81
Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of TEVA 2011-2016 81
Table Sandoz Company Profile 82
Figure Neuromyelitis Optica Drug Product Picture of Sandoz 83
Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of Sandoz 2011-2016 83
Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Sandoz 2011-2016 84
Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Sandoz 2011-2016 84
Table Intas Company Profile 85
Figure Neuromyelitis Optica Drug Product Picture of Intas 86
Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of Intas 2011-2016 86
Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Intas 2011-2016 87
Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Intas 2011-2016 87
Table Gyjtrs Company Profile 88
Figure Neuromyelitis Optica Drug Product Picture of Gyjtrs 89
Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of Gyjtrs 2011-2016 89
Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Gyjtrs 2011-2016 90
Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Gyjtrs 2011-2016 90
Table Nang Kuang Company Profile 91
Figure Neuromyelitis Optica Drug Product Picture of Nang Kuang 92
Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of Nang Kuang 2011-2016 92
Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Nang Kuang 2011-2016 93
Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Nang Kuang 2011-2016 93
Table Tianjin Kingyork Company Profile 94
Figure Neuromyelitis Optica Drug Product Picture of Tianjin Kingyork 95
Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin of Tianjin Kingyork 2011-2016 95
Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Tianjin Kingyork 2011-2016 96
Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Tianjin Kingyork 2011-2016 96
Table Baxter Company Profile List 97
Figure Product Picture of Baxter 98
Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin 2011-2016 98
Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Baxter 2011-2016 99
Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Baxter 2011-2016 99
Table CSL Company Profile List 100
Figure Product Picture of CSL 101
Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin 2011-2016 101
Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of CSL 2011-2016 102
Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of CSL 2011-2016 102
Table Grifols Company Profile List 103
Figure Grifols IVIG Flebogamma® 10% DIF Product 104
Table Grifols IVIG Flebogamma® 10% DIF Packaging Standards 104
Figure Grifols IVIG Flebogamma® 5% DIF Product 105
Table Grifols IVIG Flebogamma® 5% DIF Packaging Standards 105
Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin 2011-2016 106
Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Grifols 2011-2016 106
Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Grifols 2011-2016 107
Table Octapharma Company Profile List 107
Figure Product Picture of Octapharma 108
Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin 2011-2016 108
Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of Octapharma 2011-2016 109
Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of Octapharma 2011-2016 110
Table CBOP Company Profile List 110
Figure Picture of CBOP 111
Table Neuromyelitis Optica Drug Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Gross (USD/Unit), Revenue (K USD) and Gross Margin 2011-2016 111
Figure Neuromyelitis Optica Drug Capacity (K Units), Production (K Units) and Growth Rate of CBOP 2011-2016 112
Figure Neuromyelitis Optica Drug Production (K Units) and Global Market Share of CBOP 2011-2016 112
Figure Marketing Channels of Neuromyelitis Optica Drug 113
Table Traders or Distributors with Contact Information of Neuromyelitis Optica Drug by Regions 113
Figure Ex-work Price, Channel Price and End Buyer Price of Neuromyelitis Optica Drug (USD/Unit) in 2015 115
Table Regional Import, Export, and Trade of Neuromyelitis Optica Drug (K Units) 2011-2016 115
Table Flow of International Trade in 2015 116
Table Major Raw Materials Suppliers with Contact Information of Neuromyelitis Optica Drug 117
Table Major Equipment Suppliers with Contact Information of Neuromyelitis Optica Drug 118
Table Major Consumers with Contact Information of Neuromyelitis Optica Drug 118
Figure Supply Chain Relationship Analysis of Neuromyelitis Optica Drug 120
Table Global Capacity (K Units) of Neuromyelitis Optica Drug by Regions 2016-2021 121
Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Regions in 2016 121
Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Regions in 2021 122
Table Global Production (K Units) of Neuromyelitis Optica Drug by Regions 2016-2021 122
Figure Global Production Market Share of Neuromyelitis Optica Drug by Regions in 2016 123
Figure Global Production Market Share of Neuromyelitis Optica Drug by Regions in 2021 123
Table Global Revenue (K USD) of Neuromyelitis Optica Drug by Regions 2016-2021 123
Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Regions in 2016 124
Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Regions in 2021 124
Figure Global Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 125
Figure Global Capacity Utilization Rate of Neuromyelitis Optica Drug 2016-2021 125
Figure Global Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 126
Figure North America Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 126
Figure North America Capacity Utilization Rate of Neuromyelitis Optica Drug 2016-2021 127
Figure North America Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 127
Figure Europe Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 128
Figure Europe Capacity Utilization Rate of Neuromyelitis Optica Drug 2016-2021 128
Figure Europe Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 129
Figure China Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 129
Figure China Capacity Utilization Rate of Neuromyelitis Optica Drug 2016-2021 130
Figure China Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 130
Figure Asia (Ex China) Capacity (K Units), Production (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 131
Figure Asia (Ex China) Capacity Utilization Rate of Neuromyelitis Optica Drug 2016-2021 131
Figure Asia (Ex China) Revenue (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 132
Table Global Capacity (K Units) of Neuromyelitis Optica Drug by Types 2016-2021 132
Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Types in 2016 133
Figure Global Capacity Market Share of Neuromyelitis Optica Drug by Types in 2021 133
Table Global Production (K Units) of Neuromyelitis Optica Drug by Types 2016-2021 133
Figure Global Production Market Share of Neuromyelitis Optica Drug by Types in 2016 134
Figure Global Production Market Share of Neuromyelitis Optica Drug by Types in 2021 134
Table Global Revenue (K USD) of Neuromyelitis Optica Drug by Types 2016-2021 135
Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Types in 2016 135
Figure Global Revenue Market Share of Neuromyelitis Optica Drug by Types in 2021 136
Table Global Consumption Volume (K Units) of Neuromyelitis Optica Drug by Regions 2016-2021 136
Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Regions in 2016 137
Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Regions in 2021 137
Table Global Consumption Value (K USD) of Neuromyelitis Optica Drug by Regions 2016-2021 138
Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Regions in 2016 138
Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Regions in 2021 139
Figure Global Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 139
Figure Global Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 140
Figure North America Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 140
Figure North America Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 141
Figure Europe Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 141
Figure Europe Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 142
Figure China Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 142
Figure China Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 143
Figure Asia (Ex China) Consumption Volume (K Units) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 143
Figure Asia (Ex China) Consumption Value (K USD) and Growth Rate of Neuromyelitis Optica Drug 2016-2021 144
Table Global Consumption Volume (K Units) of Neuromyelitis Optica Drug by Types 2016-2021 144
Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Types in 2016 145
Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Types in 2021 145
Table Global Consumption Value (K USD) of Neuromyelitis Optica Drug by Types 2016-2021 145
Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Types in 2016 146
Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Types in 2021 146
Table Global Consumption Volume (K Units) of Neuromyelitis Optica Drug by Applications 2016-2021 147
Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Applications in 2016 147
Figure Global Consumption Volume Market Share of Neuromyelitis Optica Drug by Applications in 2021 148
Table Global Consumption Value (K USD) of Neuromyelitis Optica Drug by Applications 2016-2021 148
Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Applications in 2016 149
Figure Global Consumption Value Market Share of Neuromyelitis Optica Drug by Applications in 2021 149
Table Global Supply, Consumption and Gap of Neuromyelitis Optica Drug 2016-2021 (K Units) 150
Table North America Supply, Consumption and Gap of Neuromyelitis Optica Drug 2016-2021 (K Units) 150
Table Europe Supply, Consumption and Gap of Neuromyelitis Optica Drug 2016-2021 (K Units) 150
Table China Supply, Consumption and Gap of Neuromyelitis Optica Drug 2016-2021 (K Units) 150
Table Asia (Ex China) Supply, Consumption and Gap of Neuromyelitis Optica Drug 2016-2021 (K Units) 151
Table Global Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2016-2021 151
Table North America Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2016-2021 152
Table North America Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 (K Units) 152
Table Europe Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2016-2021 152
Table Europe Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 (K Units) 153
Table China Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2016-2021 153
Table China Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 (K Units) 154
Table Asia (Ex China) Capacity (K Units), Production (K Units), Price (USD/Unit), Cost (USD/Unit), Revenue (K USD) and Gross Margin of Neuromyelitis Optica Drug 2016-2021 154
Table Asia (Ex China) Supply, Import, Export and Consumption of Neuromyelitis Optica Drug 2016-2021 (K Units) 154
Table New Project SWOT Analysis of Neuromyelitis Optica Drug 155
Table Project Appraisal and Financing 156
Table New Project Construction Period 156
Table New Project Investment Feasibility Analysis of Neuromyelitis Optica Drug 156

Menu 2

Sed ut perspiciatis unde omnis iste natus error sit voluptatem accusantium doloremque laudantium, totam rem aperiam.

Menu 3

Eaque ipsa quae ab illo inventore veritatis et quasi architecto beatae vitae dicta sunt explicabo.